SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN ISSUER
PURSUANT
TO RULE 13a-16 OR 15b-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of December, 2024
Cresud
Sociedad Anónima, Comercial,
Inmobiliaria,
Financiera y
Agropecuaria
(Exact name of Registrant as specified in its
charter)
Cresud Inc.
(Translation of registrant´s name into
English)
Republic
of Argentina
(Jurisdiction of incorporation or organization)
Carlos
Della Paolera 261
(C1001ADA)
Buenos
Aires, Argentina
(Address of principal
executive offices)
Form 20-F ⌧ Form
40-F ☐
Indicate by
check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes o No
x
CRESUD
S.A.C.I.F. and A.
(THE
“COMPANY”)
REPORT
ON FORM 6-K
Attached is an
English translation of the letter dated December 6, 2024, filed by
the Company with the Bolsa de Comercio de Buenos Aires and the
Comisión Nacional de Valores.
Buenos Aires,
Argentina – December 6, 2024 – Cresud Sociedad
Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria
(the “Company”) (NASDAQ: CRESY,
BYMA:CRES), informs
that between November 17 and 25, 2024, certain warrants holders
have exercised their right to acquire additional shares.
Therefore, a total of 4,501,293 ordinary shares of the Company will be registered,
with a face value of ARS 1. As a result of the exercise, USD
1,809,070 were
collected by the Company.
After the exercise of these warrants, the number of shares and the
capital stock of the Company increased from
598,639,142
to 603,140,435, and the number of outstanding warrants
decreased from
84,261,280
to 81,063,170.
The
following table provides a summary of the information regarding the
options and shares issued by the Company:
Ordinary
shares prior to Nov-2024 exercise
|
598,639,142
|
Warrants
exercised in Nov-2024
|
3,198,110
|
Current
Ratio (ordinary shares of face value of ARS 1 per
warrant)
|
1.4075
|
Current
exercise price (per ordinary share of face value of ARS
1)
|
USD
0.4019
|
Shares
issued for Nov-2024 exercise*
|
4,501,293
|
|
|
Outstanding
Warrants after Nov-2024 exercise
|
81,063,170
|
Shares
to be issued upon warrant exercise
|
114,096,411
|
|
|
Outstanding
ordinary shares after Nov-2024 exercise
|
603,140,435
|
Fully
Diluted
|
717,236,846
|
*The
amount includes rounding adjustments for each exercise instruction
calculation.